.jpg)
For many years, doctors rarely recommended genetic testing for people with Alzheimer’s disease. Because there were no treatments that targeted the underlying cause of the illness, knowing your genetic makeup didn't change how you were cared for.
However, the recent approval of new medications is changing everything. Today, a specific gene called APOE (Apolipoprotein E) has become a vital piece of the puzzle for patients and their families.
Everyone inherits two copies of the APOE gene (one from each parent). This gene comes in three common types:
New "amyloid-lowering" drugs, which work by removing sticky plaques from the brain, interact differently with your body depending on your APOE type.
The primary reason doctors now recommend genetic testing is safety. Clinical trials found that people with the Type 4 gene are at a higher risk for a side effect known as ARIA (Amyloid-Related Imaging Abnormalities).
ARIA usually involves temporary swelling or small spots of bleeding in the brain. While most cases do not cause noticeable symptoms, some can be serious. Knowing your genetic type helps your medical team:
While the science is complex, the goal is simple: personalized care. By understanding your genetic blueprint, you and your doctor can make the safest and most informed choices for your health.
Compliance Note: This article is designed to provide general information about medical developments and does not replace professional medical advice. In accordance with European health information standards and privacy laws (such as GDPR), genetic data is considered highly sensitive. Always ensure that genetic testing is conducted through certified clinical providers who offer full data protection and pre-test counseling.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10783973/pdf/CPJ-2023-000319.pdf